-transparent.png){kind=logo}
The clinical significance of Iso-volume FEF25-75% in assessing airway responsiveness to an inhaled bronchodilator was evaluated in 167 asthmatics who presented with variable degrees of airway dysfunction. Iso-volume FEF25-75% identified responsiveness in one patient (5%) out of 20 of the most dysfunctional asthmatics, in three (20%) out of 15 of the least dysfunctional asthmatics and over-all in four (8%) out of 47 asthmatics not showing significant responsiveness via the FEV1. Over-all, FEV1 identified significant responsiveness in more patients (68.6%) than did the Iso-volume FEF25-75% (61%). The authors conclude that the Iso-volume FEF25-75% adds little to the FEV1 in the assessment of obviously dysfunctional asthmatics, the FEF25-75% as conventionally measured is a relatively useless post-bronchodilator measurement and that the FEV1 remains the single best spirometric test with which to assess airway responsiveness in asthmatics.
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
March 1978,
The American review of respiratory disease,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
June 2020,
Lung,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
December 2022,
BMC pulmonary medicine,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
September 2003,
Pediatric pulmonology,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
January 2008,
Internal medicine (Tokyo, Japan),
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
March 1980,
The Medical journal of Australia,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
March 2009,
Primary care respiratory journal : journal of the General Practice Airways Group,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
April 1983,
Acta medica Okayama,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
May 1969,
Review of allergy,
P B Boggs, and
K D Bhat, and
W A Vekovius, and
M S Debo
May 1978,
Chest,
